| Literature DB >> 31803325 |
Eman Albataineh1, Enas Al-Zayadneh2, Hani Al-Shagahin3, Ahlam Al Soloman4, Areej Altarawneh5, Ibrahim Aldmour6.
Abstract
BACKGROUND: Asthma is a highly prevalent condition that remains difficult to control, as its associated factors remain poorly understood. Thus, the primary aim of the present investigation was to determine the prevalence of uncontrolled asthma in hospital units in south Jordan and to evaluate the risk factors that may contribute to uncontrolled asthma.Entities:
Keywords: Asthma control; Asthma severity; Atopy
Year: 2019 PMID: 31803325 PMCID: PMC6879035 DOI: 10.14740/jocmr4021
Source DB: PubMed Journal: J Clin Med Res ISSN: 1918-3003
Characteristics of the Study Population
| Variable | Mean ± SD | Number (N = 93) | Percentage |
|---|---|---|---|
| Weight (kg) | 73.25 ± 13.3 | ||
| Height (cm) | 163.3 ± 9.6 | ||
| Body mass index (kg/m2) | 27.6 ± 5.0 | ||
| Age (years) | 40.5 ± 13.6 | ||
| Duration of asthma diagnosis (years) | 7.3 ± 7.9 | ||
| Gender | |||
| Male | 34 | 36.6 | |
| Female | 59 | 63.4 | |
| Atopy | |||
| Positive | 54 | 58.1 | |
| Negative | 39 | 41.9 | |
| Allergic to two or more allergens | 33 | 35.5 | |
| Allergic to three or more allergens | 13 | 14 | |
| Mean asthma control test score | 16.6 ± 6.0 | ||
| Asthma control test | |||
| Controlled | 42 | 45.2 | |
| Partially controlled | 17 | 18.3 | |
| Uncontrolled | 34 | 36.6 | |
| GINA classification | |||
| Intermittent | 28 | 30.1 | |
| Mild persistent | 40 | 43.0 | |
| Moderate persistent | 20 | 21.5 | |
| Severe persistent | 5 | 5.4 | |
| Smoking history | |||
| Positive | 26 | 28 | |
| Negative | 67 | 72 | |
| Influenza vaccination history | |||
| Positive | 28 | 30.1 | |
| Negative | 65 | 69.9 | |
| Comorbidity | |||
| Allergic rhinitis | 62 | 66.7 | |
| Allergic conjunctivitis | 46 | 49.5 | |
| Food allergy | 5 | 5.4 | |
| Eczema | 24 | 25.8 | |
| Other chronic disease | 26 | 28 | |
| Presence of chronic disease | |||
| Yes | 26 | 28 | |
| No | 67 | 72 | |
| Treatment | |||
| Inhaled corticosteroids | 36 | 38.7 | |
| Oral β2-agonist | 19 | 20.4 | |
| Inhaled β2-agonist | 62 | 66.7 | |
| No treatment | 21 | 22.6 |
GINA: Global Initiative for Asthma; SD: standard deviation.
Baseline Characteristics of the Overall Sample for Controlled, Partly Controlled and Uncontrolled Asthma
| Controlled asthma (n, %) | Partly controlled asthma (n, %) | Uncontrolled asthma (n, %) | P | |
|---|---|---|---|---|
| Total study group (n = 93) | ||||
| Sex | ||||
| Female | 27 (29) | 13 (14) | 19 (20.4) | |
| Male | 15 (16.1) | 4 (4.3) | 15 (16.1) | |
| Age group | 0.00 | |||
| < 55 years | 42 (45.2) | 14 (15.1) | 21 (22.6) | |
| ≥ 55 years | 0 | 3 (3.2) | 13 (14) | |
| Body mass index (kg/m2) | ||||
| < 30 | 30 (32.3) | 14 (15.1) | 24 (25.8) | |
| ≥ 30 | 12 (12.9) | 3 (3.2) | 10 (10.8) | |
| Duration of asthma diagnosis (years) | 5.4 | 7.1 | 9.7 | 0.037 |
| Atopy | 0.00 | |||
| Positive | 12 (12.9) | 13 (14) | 29 (31.2) | |
| Negative | 30 (32.3) | 4 (4.3) | 5 (5.4) | |
| Allergic to two or more allergens | 4 (4.3) | 9 (9.7) | 20 (21.5) | 0.00 |
| Allergic to three or more allergens | 2 (2.2) | 2 (2.2) | 9 (9.7) | 0.024 |
| Comorbidity | 0.015 | |||
| Allergic rhinitis | 23 (24.7) | 10 (10.8) | 29 (31.2) | |
| Allergic conjunctivitis | 22 (23.7) | 12 (12.9) | 12 (12.9) | |
| Food allergy | 1 (1.1) | 2 (2.2) | 2 (2.2) | |
| Eczema | 9 (9.7) | 7 (7.5) | 8 (8.6) | |
| Other chronic disease | 10 (10.8) | 3 (3.2) | 13 (14) | |
| History of smoking | ||||
| Positive | 12 (12.9) | 4 (4.3) | 10 (10.8) | |
| Negative | 30 (32.3) | 13 (14) | 24 (25.8) | |
| Presence of chronic disease | ||||
| Yes | 10 (10.8) | 3 (3.2) | 13 (14) | |
| No | 32 (34.4) | 14 (15.1) | 21 (22.6) | |
| History of flu-vaccine | ||||
| Positive | 14 (15.1) | 5 (5.4) | 9 (9.7) | |
| Negative | 28 (30.1) | 12 (12.9) | 25 (26.9) | |
| Treatment | 0.02 | |||
| Yes | 28 (30.1) | 17 (18.3) | 27 (29) | |
| No | 14 (15.1) | 0 | 7 (7.5) |
Absolute number and percentage in brackets.
Frequency of GINA-Based Asthma Severity Cases in the Controlled and Uncontrolled Asthma Groups
| GINA | Asthma control test | Chi-squared | P | |
|---|---|---|---|---|
| Controlled (n, %) | Uncontrolled (n, %) | |||
| Intermittent | 20 (21.5%) | 8 (8.6%) | 20.97 | 0.00 |
| Mild persistent | 19 (20.4%) | 21 (22.6%) | ||
| Moderate persistent | 1 (1.1%) | 19 (20.4%) | ||
| Severe persistent | 2 (2.2%) | 3 (3.2%) | ||
Absolute number and percentage in brackets. GINA: Global Initiative for Asthma.
Figure 1Frequency of GINA-based asthma severity cases in the controlled and uncontrolled asthma groups. GINA: Global Initiative for Asthma.
Figure 2The frequency of aero-allergen sensitivity in controlled and uncontrolled asthma groups.
Figure 3Asthma treatment with inhaled corticosteroids, inhaled β2-agonist and oral β2-agonist in the controlled and uncontrolled asthma groups.
Frequency of Positive Allergy Tests for Patients Taking and Not Taking Inhaled Corticosteroids
| Allergy test | Inhaled corticosteroids | Chi-squared | P | |
|---|---|---|---|---|
| No, N (%) | Yes, N (%) | |||
| Negative | 33 (61.1) | 21 (38.9) | 0.002 | > 0.05 |
| Positive | 24 (61.5) | 15 (38.5) | ||
Absolute number and percentage in brackets.
Factors Associated With Uncontrolled Asthma Obtained via MLR Analysis
| Variable | Adjusted OR | 95% CI (OR) | χ2 Stat. (df) | P |
|---|---|---|---|---|
| GINA | 2.2 | 1.011 - 4.714 | 4.0 | 0.047 |
| Allergy positive to two allergens or more | 17.2 | 4.301 - 68.702 | 16.2 | 0.00 |
MLR: multiple logistic regression; GINA: Global Initiative for Asthma; OR: odds ratio; CI: confidence interval.